Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jagust

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S Research & Therapy|May 15, 2020
Relevance of biomarkers across different neurodegenerative diseasesAlexander J Ehrenberg, Ayesha Khatun, Emma Coomans, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S Research & Therapy|June 11, 2020
Correction to: Relevance of biomarkers across different neurodegenerative diseasesAlexander J Ehrenberg, Ayesha Khatun, Emma Coomans, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2013
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2021
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's diseaseDallas P Veitch, Michael W Weiner, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2023
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022Dallas P Veitch, Michael W Weiner, Melanie Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4Michael W Weiner, Dallas P Veitch, Melanie J Miller, et al.
Alzheimer'S Research & Therapy|February 2, 2019
<sup>18</sup>F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2026
Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025)Shaveta Kanoria, Dallas P Veitch, Melanie J Miller, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S Research & Therapy|May 15, 2020
Relevance of biomarkers across different neurodegenerative diseasesAlexander J Ehrenberg, Ayesha Khatun, Emma Coomans, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S Research & Therapy|June 11, 2020
Correction to: Relevance of biomarkers across different neurodegenerative diseasesAlexander J Ehrenberg, Ayesha Khatun, Emma Coomans, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2013
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2021
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's diseaseDallas P Veitch, Michael W Weiner, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2023
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022Dallas P Veitch, Michael W Weiner, Melanie Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4Michael W Weiner, Dallas P Veitch, Melanie J Miller, et al.
Alzheimer'S Research & Therapy|February 2, 2019
<sup>18</sup>F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesRichard M Tsai, Alexandre Bejanin, Orit Lesman-Segev, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2026
Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025)Shaveta Kanoria, Dallas P Veitch, Melanie J Miller, et al.
Pageof 10